Drugs / 11-valent pneumococcal vaccine GSK513026
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00327665 | May 2006 → Jan 2007 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11-valent pneumococcal vaccine GSK513026 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00327665 ↗ |
| Modality | Vaccine | “Investigational Pneumococcal Vaccine Formulations” NCT00327665 ↗ |
| Route | Intramuscular | “Two-dose intramuscular injection.” NCT00327665 ↗ |